Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00508-021-01890-3 http://scihub22266oqcxt.onion/10.1007/s00508-021-01890-3 34129096!8204731!34129096     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Wien+Klin+Wochenschr 2021 ; 133 (17-18): 902-908 Nephropedia Template TP {{tp|p=34129096|t=2021. COVID-19-associated myoclonus in a series of five critically ill patients |pdf=|usr=}}{{34129096}} gab.com Text COVID-19-associated myoclonus in a series of five critically ill patients JO: Wien Klin Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=34129096 #FOAvip BACKGROUND: In addition to respiratory symptoms, many patients with coronavirus disease 2019 (COVID-19) present with neurological complications. Several case reports and small case series described myoclonus in five patients suffering from the disease. The purpose of this article is to report on five critically ill patients with COVID-19-associated myoclonus. MATERIAL AND METHODS: The clinical courses and test results of patients treated in the study center ICU and those of partner hospitals are described. Imaging, laboratory tests and electrophysiological test results are reviewed and discussed. RESULTS: In severe cases of COVID-19 myoclonus can manifest about 3 weeks after initial onset of symptoms. Sedation is sometimes effective for symptom control but impedes respiratory weaning. No viral particles or structural lesions explaining this phenomenon were found in this cohort. CONCLUSION: Myoclonus in patients with severe COVID-19 may be due to an inflammatory process, hypoxia or GABAergic impairment. Most patients received treatment with antiepileptic or anti-inflammatory agents and improved clinically. Twit Text FOAVip COVID-19-associated myoclonus in a series of five critically ill patients ????Wien Klin Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=34129096 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34129096 #FOAvip English Wikipedia <ref>{{Cite pmid|34129096}}</ref> COVID-19-associated myoclonus in a series of five critically ill patients #MMPMID34129096 Grieb A; Seitz T; Kitzberger R; Schmidbauer M; Hoepler W; Baumgartner S; Traugott MT; Pawelka E; Karolyi M; Strasser G; Knibbe K; Laferl H; Zoufaly A; Wenisch C; Neuhold S Wien Klin Wochenschr 2021[Sep]; 133 (17-18): 902-908 PMID34129096show ga BACKGROUND: In addition to respiratory symptoms, many patients with coronavirus disease 2019 (COVID-19) present with neurological complications. Several case reports and small case series described myoclonus in five patients suffering from the disease. The purpose of this article is to report on five critically ill patients with COVID-19-associated myoclonus. MATERIAL AND METHODS: The clinical courses and test results of patients treated in the study center ICU and those of partner hospitals are described. Imaging, laboratory tests and electrophysiological test results are reviewed and discussed. RESULTS: In severe cases of COVID-19 myoclonus can manifest about 3 weeks after initial onset of symptoms. Sedation is sometimes effective for symptom control but impedes respiratory weaning. No viral particles or structural lesions explaining this phenomenon were found in this cohort. CONCLUSION: Myoclonus in patients with severe COVID-19 may be due to an inflammatory process, hypoxia or GABAergic impairment. Most patients received treatment with antiepileptic or anti-inflammatory agents and improved clinically. |*COVID-19[MESH] |*Myoclonus/chemically induced/diagnosis/drug therapy[MESH] |Critical Illness[MESH] |Humans[MESH] |Intensive Care Units[MESH]COVID-19-associated myoclonus in a series of five critically ill patie(epmc).pdf DeepDyve Pubget Overpricing